• Pertussis Toxin in TREM2–Microglia Assays

  2026-10-01

  Pertussis toxin can serve as an orthogonal cAMP-signaling perturbation in studies of TREM2-regulated microglial inflammation. This article connects toxin mechanism, experimental autoimmune uveitis, assay design, and interpretation without confusing pathway probing with disease-model evidence.

• GA–ATG8 Autophagy Promotes Arabidopsis Germination

  2026-10-01

  This Arabidopsis study identifies an autophagic route that complements proteasomal DELLA degradation during gibberellin signaling under nutrient starvation and darkness. The findings connect GA-dependent GID1–ATG8 interactions with DELLA clearance, seed germination, and skotomorphogenesis, while offering a useful framework for separating pathway mechanism from phenotypic consequence.

• Tetracycline Hydrochloride: Assay Workflows

  2026-09-30

  Build reproducible bacterial translation, Staphylococcus aureus susceptibility, and microbiome-oriented assays with Tetracycline Hydrochloride. The workflow also clarifies why its ribosomal, bacteriostatic profile should not be conflated with the rapid ROS-driven cancer-cell death reported for carrier-platin.

• Matrine: Mechanisms, Evidence, and Assay Design

  2026-09-30

  Matrine is a Sophora-derived quinolizidine alkaloid with reported anticancer and anti-inflammatory activity. Current evidence supports apoptosis induction, reduced stemness-associated phenotypes, and candidate YTHDF1–Wnt/β-catenin involvement in thymoma cells, but it does not establish clinical efficacy or a definitive m6A mechanism.

• Dibutyryl-cAMP, Sodium Salt in Decidualization

  2026-09-29

  Explore how Dibutyryl-cAMP, sodium salt functions as a controllable cAMP stimulus in endometrial decidualization research. This article translates ACSL4 and fatty-acid β-oxidation findings into practical assay-design decisions beyond conventional cAMP pathway studies.

• L-Threonine Workflows for Metabolic Research

  2026-09-29

  L-Threonine is best used as a controlled nutrient variable for cell culture optimization, metabolic profiling, and nutritional intervention studies—not as a direct alkaline phosphatase reagent. This workflow pairs disciplined amino acid handling with a separate metal-free carbon-dot ALP assay to reduce matrix confusion and improve experimental interpretation.

• Asunaprevir (BMS-650032): HCV NS3 Inhibition

  2026-09-28

  Asunaprevir, also called BMS-650032, is a noncovalent HCV NS3 protease inhibitor with a reported enzyme IC50 of 1 nM. Product data describe genotype-spanning biochemical activity, HCV RNA replication inhibition in multiple cell types, oral efficacy, and liver-relevant disposition, while supporting research use rather than unqualified clinical extrapolation.

• Benzyl Quinolone Carboxylic Acid (BQCA): Evidence & Use

  2026-09-28

  Benzyl Quinolone Carboxylic Acid (BQCA) is a positive allosteric modulator used to investigate M1 muscarinic acetylcholine receptor signaling. Evidence supports acetylcholine potentiation and preclinical neuronal responses, but does not establish clinical benefit or a universal assay protocol.

• BQCA Workflows for M1 Receptor Signaling

  2026-09-27

  Use BQCA to probe how allosteric enhancement of M1 acetylcholine receptor signaling changes G-protein and β-arrestin responses—not simply whether a receptor turns on. This workflow-led guide combines concentration-response design, BRET-based interaction assays, and practical handling controls for cognitive and Alzheimer’s disease research.

• NBC19 for NLRP3 Inflammasome Research

  2026-09-26

  Use NBC19 to test how NLRP3 activity contributes to IL-1β release, with reported nanomolar activity in differentiated THP1 cells. A practical workflow pairs trigger-specific dose curves with viability controls—and treats cancer-associated macrophage-like cell studies as an exploratory extension, not an established application.

• GANT61 Targets the Hh–PIK3IP1–Akt Axis in ALK+ ALCL

  2026-09-25

  A 2026 study reports that the Hedgehog-pathway inhibitor GANT61 reduces proliferation and promotes cell-cycle arrest and apoptosis in ALK-positive anaplastic large cell lymphoma cell lines. The findings connect Gli1 inhibition with increased PIK3IP1 and reduced Akt phosphorylation, suggesting a signaling relationship that merits further testing rather than establishing a clinical treatment strategy.

• BQCA Workflows for M1 Receptor Signaling

  2026-09-25

  Use BQCA to separate increased acetylcholine potency from changes in maximal M1-receptor signaling, then track how the response develops across G-protein, β-arrestin, and GRK readouts. This workflow connects receptor-level assays to neuronal activity research while highlighting controls that help distinguish allosteric potentiation from assay-specific agonism.

• hiPSC Intestinal Organoids for Pharmacokinetic Studies

  2026-09-24

  Saito and colleagues describe a direct 3D cluster-culture approach for generating expandable human iPSC-derived intestinal organoids that can be cryopreserved and differentiated into functional intestinal epithelial cells. The study supports their use in human-relevant pharmacokinetic research while highlighting the need to validate individual drug-metabolizing enzymes, not infer their activity from general CYP readouts.

• Wnt-C59: Mapping Wnt Secretion in Research

  2026-09-24

  Use Wnt-C59 to test whether a phenotype depends on PORCN-mediated Wnt secretion—not simply on downstream β-catenin activity. This workflow connects cancer-cell assays with a carefully qualified extension to lithium-engineered BMSC exosomes and osteogenesis.

• Intestinal TM6SF2 Protects Against MASH

  2026-09-23

  A 2025 Nature Metabolism study shows that intestinal TM6SF2 helps protect against MASH by maintaining barrier function and limiting microbiota-associated lysophosphatidic acid signaling to the liver. Genetic deletion, microbiota-transfer experiments, and pharmacological intervention connect intestinal changes to hepatic disease, while identifying important questions for follow-up studies.

8178 records 1/546 page Next 12345 下5页 Last page